Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03753412 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

Study acronym: CLEVERER
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 7, 2026 (before its estimated September 26, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Sep 26, 2025 to Sep 26, 2026v14
  2. Primary and study completion dates: Sep 26, 2024 to Sep 26, 2025v13
  3. Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: Sep 26, 2023 to Sep 26, 2024
    • Site details revised
    v12
  4. Re-verified, no change to tracked fieldsv11
  5. Primary and study completion dates: Aug 2, 2022 to Sep 26, 2023v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary and study completion dates: Aug 2, 2021 to Aug 2, 2022
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v9
  2. Primary and study completion dates: Aug 1, 2020 to Aug 2, 2021v8
  3. 2 versions Re-verified since May 28, 2019, no change to tracked fieldsv6-v7
  4. Start date changed from estimate of Mar 27, 2019 to Apr 9, 2019v5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  6. Start date: Feb 8, 2019 to Mar 27, 2019v3
  7. Start date: Jan 1, 2019 to Feb 8, 2019v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
Trial Details
NCT Number NCT03753412
Lead Sponsor Barts & The London NHS Trust
Collaborators: Queen Mary University of London
Conditions
(from sponsor)		 Intensive Care Unit Syndrome, Intensive Care Neuropathy, Intensive Care (ICU) Myopathy, Acute Respiratory Distress Syndrome, Cardiac Failure, Respiratory Failure, Critical Illness Myopathy
Related terms Heart Failure, Muscular Diseases, Respiratory Distress Syndrome, Respiratory Insufficiency
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov